You have 9 free searches left this month | for more free features.

City

Condition

Cholangiocarcinoma (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

Sponsor

First Affiliated Hospital Xi'an Jiaotong University (1)

Collaborator

Intervention

carrelizumab (1)

solfantinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

solfantinib

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Cholangiocarcinoma Trial (Carrelizumab, Solfantinib)

Not yet recruiting

Cholangiocarcinoma

Carrelizumab
Solfantinib

(no location specified)

Jan 16, 2023